Eric Dube | executive |
Jula Inrig | executive |
Peter Heerma | executive |
Chris Cline | executive |
Joseph Schwartz | analyst |
Greg Harrison | analyst |
Anupam Rama | analyst |
Tyler Van Buren | analyst |
William Rote | executive |
Carter L. Gould | analyst |
Maurice Raycroft | analyst |
John Boyle | analyst |
Liisa Bayko | analyst |
Mohit Bansal | analyst |
Antonio Arce | analyst |
Laura Chico | analyst |
Good day, and welcome to the Travere Therapeutics Fourth Quarter and Full Year 2023 Financial Results and Corporate Update Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference call over to [indiscernible]. Please go ahead, ma'am.
Thanks, Jenny.